“We encourage researchers to apply if they are currently engaged in research on COVID-19. We have primarily offered our computing capacity to some of our major users, such as the Institute of Organic Chemistry and Biochemistry of the CAC and CEITEC. But others can apply too. In addition, projects supported do not necessarily need to be focused on just drug development but may also be the development of nanomaterials to support the fight against coronavirus or to model the spread of the epidemic” says Vít Vondrák, IT4Innovations’ Managing Director.
“In the Czech Republic, we have great researchers who can greatly help with the management of this pandemic and its consequences using high-performance computers for useful calculations. With a joint performance of about 1 PFlop per second, our supercomputers can count thousands of times faster than standard computers, enabling scientists to now save so much valuable time” said Vladek Šlezingr, CEO at Atos in the Czech Republic, who designed and delivered the Atos supercomputers Anselm and Barbora.
